This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Natco Pharma Limited. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: The Innovative Contributions of Kotayya Babu Sikha
Introduction
Kotayya Babu Sikha is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer drugs. With a total of three patents to his name, Sikha has established himself as a key figure in the industry.
Latest Patents
One of his latest patents includes the anhydrous polymorphic form-I of the anti-cancer drug Lenalidomide. The chemical name for this compound is 3-(4-amino-1-oxo-1,3-dihydro-isoindole-2-yl)-piperidine-2,6-dione. This patent discloses alternate methods for making the anhydrous polymorphic form-I of Lenalidomide, showcasing his innovative approach to drug formulation.
Career Highlights
Kotayya Babu Sikha is currently associated with Natco Pharma Limited, a leading pharmaceutical company. His work at Natco Pharma has allowed him to focus on developing new and effective treatments for cancer, contributing to advancements in medical science.
Collaborations
He has collaborated with notable coworkers such as Durga Prasad Konakanchi and Buchappa Gongalla, further enhancing the innovative environment at Natco Pharma.
Conclusion
Kotayya Babu Sikha's contributions to the pharmaceutical industry, particularly in the development of Lenalidomide, highlight his role as an influential inventor. His work continues to impact the field of cancer treatment, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile